首页> 外文期刊>Science China Life Sciences >Platelet proteomics and its advanced application for research of blood stasis syndrome and activated blood circulation herbs of Chinese medicine
【24h】

Platelet proteomics and its advanced application for research of blood stasis syndrome and activated blood circulation herbs of Chinese medicine

机译:血小板蛋白质组学及其在血瘀证和活血化瘀药研究中的先进应用

获取原文
获取原文并翻译 | 示例
       

摘要

The development of novel and efficient antiplatelet agents that have few adverse effects and methods that improve antiplatelet resistance has long been the focus of international research on the prevention and treatment of cardiovascular and cerebrovascular diseases. Recent advances in platelet proteomics have provided a technology platform for high-quality research of platelet pathophysiology and the development of new antiplatelet drugs. The study of blood stasis syndrome (BSS) and activated blood circulation of traditional Chinese medicine (TCM) is one of the most active fields where the integration of TCM and western medicine in China has been successful. Activated blood circulation herbs (ABC herbs) of Chinese medicine are often used in the treatment of BSS. Most ABC herbs have antiplatelet and anti-atherosclerosis activity, but knowledge about their targets is lacking. Coronary heart disease (CHD), BSS, and platelet activation are closely related. By screening and identifying activated platelet proteins that are differentially expressed in BSS of CHD, platelet proteomics has helped researchers interpret the antiplatelet mechanism of action of ABC herbs and provided many potential biomarkers for BSS that could be used to evaluate the clinical curative effect of new antiplatelet drugs. In this article the progress of platelet proteomics and its advanced application for research of BSS and ABC herbs of Chinese medicine are reviewed.
机译:长期以来,新型的,有效的抗血小板药物,不良反应少,抗血小板药性提高的研究一直是国际心脑血管疾病防治研究的重点。血小板蛋白质组学的最新进展为高质量的血小板病理生理学研究和新的抗血小板药物的开发提供了技术平台。血瘀证和中药活血化瘀的研究是中西医结合成功的最活跃的领域之一。活化血液循环中草药(ABC草药)通常用于治疗BSS。大多数ABC草药都具有抗血小板和抗动脉粥样硬化的活性,但缺乏有关其靶标的知识。冠心病(CHD),BSS和血小板活化密切相关。通过筛选和鉴定在冠心病的BSS中差异表达的活化血小板蛋白,血小板蛋白质组学帮助研究人员解释了ABC草药的抗血小板作用机制,并提供了许多潜在的BSS生物标志物,可用于评估新型抗血小板的临床疗效毒品。本文综述了血小板蛋白质组学的研究进展及其在中草药BSS和ABC中的研究进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号